Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherArticle

Identification of chemical and pharmacological chaperones for correction of trafficking- deficient mutant CNGA3 channels

Joachim Täger, Bernd Wissinger, Susanne Kohl and Peggy Reuter
Molecular Pharmacology April 7, 2021, MOLPHARM-AR-2020-000180; DOI: https://doi.org/10.1124/molpharm.120.000180
Joachim Täger
1Institute for Ophthalmic Research, Molecular Genetics Laboratory, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernd Wissinger
1Institute for Ophthalmic Research, Molecular Genetics Laboratory, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Kohl
1Institute for Ophthalmic Research, Molecular Genetics Laboratory, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peggy Reuter
1Institute for Ophthalmic Research, Molecular Genetics Laboratory, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Peggy.Reuter@med.uni-tuebingen.de
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Additional Files

  • Data Supplement

    • Supplemental Data  -

      Supplemental Methods

      Supplemental Figure 1 - Immunocytochemical staining of cytosolic and mitochondrial localized apoaequorin.

      Supplemental Figure 2 - Aequorin-mediated luminescence signal of HEK293 cells depends on the expression of CNGA3.

      Supplemental Figure 3 - Comparison of fold changes obtained with CNGA3WT and CNGA3E228K after treatment with five dihydropyridines.

      Supplemental Figure 4 -Graphical representation of the FCmax and the concentration necessary to reach FCmax for the compounds of the pyrazine amide and benzamide class

      Supplemental Table 1 - Summary of the measured fold changes (FC) of compounds analyzed with the bioassay. 

      Supplemental Table 2 - Summary of compounds tested for determining structure-activity relationship of the dihydropyridine (DHP) compound class.

      Supplemental Table 3 - Molecular structure of the additionally tested dihydropyridine (DHP) derivates.


Previous
Back to top

In this issue

Molecular Pharmacology: 99 (5)
Molecular Pharmacology
Vol. 99, Issue 5
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of chemical and pharmacological chaperones for correction of trafficking- deficient mutant CNGA3 channels
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Correction of mutant CNGA3 channel trafficking defect

Joachim Täger, Bernd Wissinger, Susanne Kohl and Peggy Reuter
Molecular Pharmacology April 7, 2021, MOLPHARM-AR-2020-000180; DOI: https://doi.org/10.1124/molpharm.120.000180

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherArticle

Correction of mutant CNGA3 channel trafficking defect

Joachim Täger, Bernd Wissinger, Susanne Kohl and Peggy Reuter
Molecular Pharmacology April 7, 2021, MOLPHARM-AR-2020-000180; DOI: https://doi.org/10.1124/molpharm.120.000180
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • 6-Methylflavone Blocks Bitterness of Tenofovir
  • Positive Allosteric Modulation of the mGlu5 Receptor
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics